Delek US (NYSE:DK) Director Shlomo Zohar Sells 22,029 Shares

Delek US Holdings, Inc. (NYSE:DK) Director Shlomo Zohar sold 22,029 shares of the firm’s stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $44.83, for a total value of $987,560.07. Following the completion of the sale, the director directly owned 18,989 shares of the company’s stock, valued at $851,276.87. This represents a 53.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shlomo Zohar also recently made the following trade(s):

• On Wednesday, March 4th, Shlomo Zohar sold 7,343 shares of Delek US stock. The stock was sold at an average price of $43.00, for a total transaction of $315,749.00.

Delek US Stock Performance

Shares of DK opened at $42.35 on Friday. The company has a market capitalization of $2.54 billion, a PE ratio of -121.00 and a beta of 0.75. Delek US Holdings, Inc. has a 52-week low of $11.02 and a 52-week high of $45.74. The company has a 50-day simple moving average of $32.38 and a 200-day simple moving average of $33.31. The company has a quick ratio of 0.58, a current ratio of 0.82 and a debt-to-equity ratio of 5.89.

Delek US (NYSE:DK) last issued its earnings results on Friday, February 27th. The oil and gas company reported $0.44 earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.63. Delek US had a negative net margin of 0.21% and a negative return on equity of 13.55%. The company had revenue of $2.43 billion for the quarter, compared to analyst estimates of $2.55 billion. During the same period in the prior year, the business posted ($2.54) earnings per share. The firm’s revenue for the quarter was up 2.3% compared to the same quarter last year. Equities research analysts predict that Delek US Holdings, Inc. will post -5.5 earnings per share for the current fiscal year.

Delek US Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 9th. Shareholders of record on Monday, March 2nd will be given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Monday, March 2nd. Delek US’s payout ratio is presently -291.43%.

Delek US News Summary

Here are the key news stories impacting Delek US this week:

• Positive Sentiment: TD Cowen raised its price target from $28 to $44 (hold), narrowing upside uncertainty and signaling improving analyst visibility. Finviz
• Positive Sentiment: Quarterly results: Delek US reported a surprise EPS beat ($0.44 vs. est. -$0.19), which is supportive for the shares despite a slight revenue shortfall. (Source: company/market coverage)
• Positive Sentiment: Dividend declared: a $0.255 quarterly dividend (annualized $1.02, ~2.3% yield) payable March 9 — offers short-term income support for the stock.
• Neutral Sentiment: Institutional activity: several large funds have adjusted positions recently (mix of increases and new stakes); institutional ownership remains high (~97%), which can both stabilize and concentrate stock moves.
• Negative Sentiment: CEO sale: CEO Avigal Soreq sold 50,000 shares (~$2.05M at ~$41.08). Large insider sales from the CEO often trigger investor concern about timing and outlook. CEO Sale — SEC filing: Form 4
• Negative Sentiment: Additional insider selling: multiple executives and directors sold sizable stakes in early March (EVPs Reuven Spiegel — 20,000 sh; Joseph Israel — 38,000 sh; Directors Shlomo Zohar and William Finnerty also sold). The cluster of senior-level sales is adding downward pressure. Relevant SEC filings: Spiegel (Read More.), Israel (Read More.), Zohar (Read More.), Finnerty (Read More.).
• Negative Sentiment: Analyst moves mixed-to-negative: Citi and Piper Sandler trimmed price targets (to $33 and $40 respectively) and Weiss reiterated a sell — these downward revisions amplify selling pressure even as some shops (e.g., Mizuho) remain bullish.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Scotiabank set a $34.00 price objective on shares of Delek US in a research note on Friday, January 16th. JPMorgan Chase & Co. lowered their price target on shares of Delek US from $42.00 to $38.00 and set a “neutral” rating on the stock in a research report on Thursday, January 15th. Piper Sandler reduced their target price on Delek US from $47.00 to $40.00 and set a “neutral” rating on the stock in a research note on Thursday, January 8th. TD Cowen raised their price target on Delek US from $28.00 to $44.00 and gave the stock a “hold” rating in a research report on Thursday. Finally, Morgan Stanley reduced their price objective on Delek US from $40.00 to $38.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 27th. Four equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $39.46.

Hedge Funds Weigh In On Delek US

Several large investors have recently added to or reduced their stakes in the business. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Delek US by 95.6% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 884 shares of the oil and gas company’s stock worth $26,000 after acquiring an additional 432 shares during the period. Brown Brothers Harriman & Co. purchased a new stake in shares of Delek US during the 3rd quarter valued at $27,000. EverSource Wealth Advisors LLC grew its stake in shares of Delek US by 173.4% during the 4th quarter. EverSource Wealth Advisors LLC now owns 968 shares of the oil and gas company’s stock valued at $29,000 after buying an additional 614 shares during the period. AlphaQuest LLC increased its holdings in shares of Delek US by 7,331.8% during the 2nd quarter. AlphaQuest LLC now owns 1,635 shares of the oil and gas company’s stock worth $35,000 after buying an additional 1,613 shares during the last quarter. Finally, Torren Management LLC acquired a new stake in shares of Delek US during the 4th quarter worth $40,000. 97.01% of the stock is currently owned by hedge funds and other institutional investors.

Delek US Company Profile

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.